| CAS: | 565460-15-3 | ||
| 分子式: | C19H21NO2 | ||
| 分子量: | 295.38 | ||
| 英文名称: |
| ||
| 用途: | URB602 是一种选择性的单酰基甘油脂肪酶 (MGL) 抑制剂,非竞争性抑制大鼠脑 MGL,IC50 为 28±4 μM。 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||
| U878421 | MACKLIN | URB602 | ≥99% | 391元/10mg; 819元/25mg; 2250元/100mg; | 咨询 | ||||||
储存:2-8℃ | |||||||||||
| U792560 | MACKLIN | URB602 | 10mM in DMSO | 852元/1ml; | 咨询 | ||||||
储存:-20°C | |||||||||||
| 233853 | Fluorochem | Cyclohexyl [1,1'-biphenyl]-3-ylcarbamate | 95% | 4532元/250mg; 11352元/1g; | 咨询 | ||||||
基本信息
| |||||||||||
| HY-100792 | MCE | URB602,565460-15-3_MCE(MedChemExpress) | 184元/10 mM * 1 mL in DMSO; 168元/5 mg; 298元/10 mg; 527元/25 mg; 870元/50 mg; 1475元/100 mg; 2212元/200 mg; | 咨询 | |||||||
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 URB602MCE 国际站:URB602 品牌:MedChemExpress (MCE) 货号:HY-100792 CAS 号:565460-15-3 生物活性:URB602 是一种选择性单酰甘油脂肪酶 (MGL) 抑制剂,它通过非竞争性机制抑制大鼠脑 MGL,IC50 为 28±4 μM。 体外研究(In Vitro):Without URB602, the apparent Michaelis constant (Km) of MGL for 2-AG is 24±1.7 μM and the maximum velocity (Vmax) is 1814±51 nmol min per mg protein; with URB602, the Km is 20±0.4 μM and the Vmax is 541±20 nmol min per mg protein (n=4). When organotypic slice cultures of rat forebrain are incubated with URB602 (100 μM), both baseline and Ca2+-ionophore-stimulated 2-arachidonoylglycerol (2-AG) concentrations are increased[1]. URB602 is an inhibitor of monoacylglycerol lipase (MGL), a serine hydrolase involved in the biological deactivation of the endocannabinoid 2-arachidonoyl-sn-glycerol (2-AG). URB602 weakly inhibits recombinant MGL (IC50=223±63 μM) through a rapid and noncompetitive mechanism[2]. MCE尚未独立确认这些方法的准确性。 仅供参考。 体内研究(In Vivo):URB602 at doses of 20 and 40 mg/kg tends to reduce upper GI transit and slow colonic propulsion. When taken together as whole gut transit, URB602 dose dependently inhibits transit (P1 receptor involvement in the inhibitory action[3]. URB602 decreases the AUC of pain behaviour during the early phase of the formalin test with an ED50 of 0.06±0.028 μg for JZL184 and 120±51.3 μg for URB602 in adult male Sprague-Dawley rats. Both MGL inhibitors also suppresses pain behaviour during the late phase of formalin pain, with an ED50 of 0.03±0.011 μg for JZL184 and 66±23.9 μg for URB602[4]. MCE尚未独立确认这些方法的准确性。 仅供参考。 分子量:295.38 Formula:C19H21NO2 性状:固体 颜色:White to off-white 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:粉末 -20°C 3年 Kinase Assay [2]:将含有 URB602 (300 μM)、MGL (1.4 pM) 或 URB602 和 MGL 的样品在测定缓冲液中于 37°C 孵育 30 分钟。在不同时间点,用等体积的冰甲醇终止反应,并直接采用正离子模式进行 LC/MS 分析。使用 SB-CN 色谱柱 (150×2.1 mm 内径,5 μm),以甲醇-水(含 0.25% 乙酸和 5 mM 乙酸铵)的线性梯度洗脱(甲醇浓度在 8 分钟内从 60% 升至 100%),流速为 0.5 mL/min,柱温为 50°C。毛细管电压设置为 4 kV,碎裂器电压设置为 100 V。雾化器压力设置为 60 psi。使用N2作为干燥气体,流量为13升/分钟,温度为350℃。 ESI 处于正模式,采集 m/z 100 至 600 范围内的全扫描谱图。提取的离子色谱图用于量化 URB602 ([M+H]+,m/z 296)[2]。 MCE 尚未独立确认这些方法的准确性。仅供参考。 Animal Administration [3][4]:Mice[3] Male C57BL/6 mice (5-6 wk; 20-26 g) or female CB1-/- mice (8 wk; 18-22 g) on a C57BL/6 background are used. After an overnight fasting period (water ad libitum), a marker is administered orally to assess upper GI transit, as described in detail by others. At 30 min after intraperitoneal (ip) administration of URB602 (20 or 40 mg/kg) or vehicle (10% DMSO/Tween 80 in saline), an oral gavage of 200 μL of an Evans blue marker (5% Evans blue, 5% gum arabic) is administered. After 15 min animals are killed by cervical dislocation and the intestine from the region of the pyloric sphincter to the ileocecal junction is immediately removed. The distance traveled by the marker is measured in centimeters and expressed as a percentage of the total length of the small intestine. Rats[4] Three hundred and seven adult male Sprague-Dawley rats weighing 275-350 g, at the time of testing, are used. In a first study, the dose-response curves for JZL184 and URB602 are determined using the AUC of Phase 1 or Phase 2 pain behaviour. In a second study, the antinociceptive effects of JZL184 (300 μg) and URB602 (600 μg) are evaluated following injection in the paw, ipsilateral or contralateral to formalin, to exclude the possibility that systemic leakage contributed to the pattern of results obtained. In a third study, antinociceptive effects of ED50 doses of JZL184 (0.03 μg i.paw) or URB602 (66 μg i.paw), in combination with 2-AG (ED50 dose of 1 μg i.paw), are quantified to evaluate the presence of additive or synergic effects of these drugs. In a fourth study, antinociceptive effects of JZL184 (at 10 μg i.paw, an analgesic dose) are studied in the presence or absence of either AM251 or AM630 to determine whether these effects are mediated through CB1 and/or CB2 receptors. The CB1 receptor antagonist AM251 exhibits 306-fold selectivity for CB1 over CB2 receptors, whereas the CB2 receptor antagonist AM630 exhibits 70-165-fold selectivity for CB2 over CB1 receptors. The doses employed (AM251 at 80 μg i.paw and AM630 at 25 μg i.paw) are those which block peripheral antinociceptive effects of URB602 in Wistar rats. For the first study (n=4-6 per group for URB602 and n=6-8 per group for JZL184) and for all the other behavioural studies (n=6 per group), drugs, administered either alone or in combination, are dissolved in the same total volume (50 μL) and injected into the right hind paw. Preliminary experiments (n=8 per group; data not shown) confirmed that formalin-induced pain behaviour did not change following intra-paw administration of either vehicle (PEG 300: Tween 80 in a 4:1 ratio or DMSO: ethanol: cremophor: 0.9% saline in a 1:1:1:17 ratio]. MCE尚未独立确认这些方法的准确性。 仅供参考。 提供质量检测报告:Data Sheet、SDS、COA、LCMS、产品使用指南 产品活性:URB602 是一种选择性的单酰基甘油脂肪酶 (MGL) 抑制剂,非竞争性抑制大鼠脑 MGL,IC50 为 28±4 μM。 IC50 & Target:IC50: 28±4 μM (rat brain MGL)[1] 相关产品:Bafilomycin A1 | Rapamycin (GMP Like) | Rapamycin | Rapamycin (Standard) | Rapamycin | Etomoxir | Etomoxir (Standard) | Y-27632 dihydrochloride | PEG300 | PEG400 | PEG100000 | PEG1000000 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: 参考文献: 品牌介绍:
| |||||||||||
| HY-100792R | MCE | URB602 (Standard),565460-15-3_MCE(MedChemExpress) | 750元/5 mg; 1200元/10 mg; 2160元/25 mg; 3450元/50 mg; 5520元/100 mg; | 咨询 | |||||||
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 URB602 (Standard)MCE 国际站:URB602 (Standard) 品牌:MedChemExpress (MCE) 货号:HY-100792R CAS 号:565460-15-3 产品简介:URB602 (Standard)是 URB602 的分析标准品。本产品用于研究及分析应用。URB602 是一种选择性的单酰基甘油脂肪酶 (MGL) 抑制剂,非竞争性抑制大鼠脑 MGL,IC50 为 28±4 μM。 产品应用:该化合物为分析标准品级别,是含量检测的分析标准品,常用于液相、气相和质谱的定性、定量及方法学研究实验中。 分子量:295.38 Formula:C19H21NO2 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:请按照分析证书中推荐的条件储存产品。 提供质量检测报告:产品使用指南 产品活性:URB602 (Standard)是 URB602 的分析标准品。本产品用于研究及分析应用。URB602 是一种选择性的单酰基甘油脂肪酶 (MGL) 抑制剂,非竞争性抑制大鼠脑 MGL,IC50 为 28±4 μM。 相关产品:Rapamycin (Standard) | Etomoxir (Standard) | Bafilomycin A1 | Rapamycin (GMP Like) | Rapamycin | Rapamycin | Y-27632 dihydrochloride (Standard) | Orlistat (Standard) | PEG1000000 | PEG200000 | PEG5000000 | PEG8000000 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: 品牌介绍:
| |||||||||||